Shares of pharmaceutical company Vertex Pharmaceuticals were falling this week after the company announced that it was going to stop testing on a drug designed to treat protein deficiencies. Based on early data of its Phase II trial of VX-814 in Alpha-1 antitrypsin deficiency (AATD), the company is halting the trial and ending development of … Continue reading “Vertex Shares Drop After Company Stops Testing on Protein Deficiency Treatment”
Tag: Vertex Pharmaceuticals
Biotech & Pharma
Crispr Therapeutics Explodes 15% After New Blood Disease Drug Gets Fast-Track
Shares of Crispr Therapeutics were on the rise since Monday, shooting up almost 15% after…
May 14, 2020